Peter Salzmann, Chief Executive Officer at Immunovant, Inc. (IMVT), sold 56,188 shares at $12.99 ($730K) on 2025-04-09, disclosed to the SEC on 2025-04-11.
Seasonal sale ($730k) by Chief Executive Officer — this insider has traded IMVT in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.99 | 28,094 | $365K | 50.0% |
| 2 | $12.99 | 28,094 | $365K | 50.0% |
| Total | $12.99 avg | 56,188 | $730K | 100% |
| Filing → |
| IMVT | SELL | 2025-01-17 | $408K | — | Filing → |
| IMVT | SELL | 2025-01-10 | $246K | — | Filing → |
| IMVT | SELL | 2024-11-22 | $850K | — | Filing → |